Cargando…
Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen
From an economic point of view, vaccine mandates are a negative incentive to get vaccinated. Positive incentives that induce unvaccinated individuals just as effectively — such as government-provided cash incentives — can be more flexible and avoid some of the other disadvantages that come with mand...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933175/ http://dx.doi.org/10.1007/s10273-022-3139-y |
_version_ | 1784671588120002560 |
---|---|
author | Stolpe, Michael |
author_facet | Stolpe, Michael |
author_sort | Stolpe, Michael |
collection | PubMed |
description | From an economic point of view, vaccine mandates are a negative incentive to get vaccinated. Positive incentives that induce unvaccinated individuals just as effectively — such as government-provided cash incentives — can be more flexible and avoid some of the other disadvantages that come with mandates and possibly achieve higher vaccination rates. Given the size of societal benefits from boosting vaccination rates in the fight against SARS-CoV-2, Germany has substantial unused financial leeway to pay for cash incentives. Prudent combinations of cash incentives and vaccine mandates are also worth considering. |
format | Online Article Text |
id | pubmed-8933175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-89331752022-03-21 Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen Stolpe, Michael Wirtschaftsdienst Analysen From an economic point of view, vaccine mandates are a negative incentive to get vaccinated. Positive incentives that induce unvaccinated individuals just as effectively — such as government-provided cash incentives — can be more flexible and avoid some of the other disadvantages that come with mandates and possibly achieve higher vaccination rates. Given the size of societal benefits from boosting vaccination rates in the fight against SARS-CoV-2, Germany has substantial unused financial leeway to pay for cash incentives. Prudent combinations of cash incentives and vaccine mandates are also worth considering. Springer Berlin Heidelberg 2022-03-19 2022 /pmc/articles/PMC8933175/ http://dx.doi.org/10.1007/s10273-022-3139-y Text en © Der/die Autor:in 2022 https://creativecommons.org/licenses/by/4.0/Open Access: Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht (https://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) ). Open Access wird durch die ZBW — Leibniz-Informationszentrum Wirtschaft gefördert. |
spellingShingle | Analysen Stolpe, Michael Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title | Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title_full | Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title_fullStr | Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title_full_unstemmed | Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title_short | Impfpflichten, Anreize und die effiziente Nutzung von Coronaimpfstoffen |
title_sort | impfpflichten, anreize und die effiziente nutzung von coronaimpfstoffen |
topic | Analysen |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933175/ http://dx.doi.org/10.1007/s10273-022-3139-y |
work_keys_str_mv | AT stolpemichael impfpflichtenanreizeunddieeffizientenutzungvoncoronaimpfstoffen |